Details
| Stereochemistry | RACEMIC |
| Molecular Formula | C23H32N2O |
| Molecular Weight | 352.513 |
| Optical Activity | ( + / - ) |
| Defined Stereocenters | 0 / 1 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
CN1CCCCC1CN2C=C(C(=O)C3C(C)(C)C3(C)C)C4=C2C=CC=C4
InChI
InChIKey=MOBWRRIAIHYXLB-UHFFFAOYSA-N
InChI=1S/C23H32N2O/c1-22(2)21(23(22,3)4)20(26)18-15-25(19-12-7-6-11-17(18)19)14-16-10-8-9-13-24(16)5/h6-7,11-12,15-16,21H,8-10,13-14H2,1-5H3
| Molecular Formula | C23H32N2O |
| Molecular Weight | 352.513 |
| Charge | 0 |
| Count |
|
| Stereochemistry | RACEMIC |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 1 |
| E/Z Centers | 0 |
| Optical Activity | ( + / - ) |
Approval Year
| Substance Class |
Chemical
Created
by
admin
on
Edited
Sat Dec 16 11:51:14 GMT 2023
by
admin
on
Sat Dec 16 11:51:14 GMT 2023
|
| Record UNII |
TPY5M47AYQ
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
WIKIPEDIA |
Designer-drugs-AB-005
Created by
admin on Sat Dec 16 11:51:14 GMT 2023 , Edited by admin on Sat Dec 16 11:51:14 GMT 2023
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
DTXSID001017492
Created by
admin on Sat Dec 16 11:51:14 GMT 2023 , Edited by admin on Sat Dec 16 11:51:14 GMT 2023
|
PRIMARY | |||
|
TPY5M47AYQ
Created by
admin on Sat Dec 16 11:51:14 GMT 2023 , Edited by admin on Sat Dec 16 11:51:14 GMT 2023
|
PRIMARY | |||
|
AB-005
Created by
admin on Sat Dec 16 11:51:14 GMT 2023 , Edited by admin on Sat Dec 16 11:51:14 GMT 2023
|
PRIMARY | AB-005 is a synthetic cannabinoid (CB) built on a 1-((1-methylpiperidin-2-yl)methyl)-indole base that is characteristic of a series of potent CBs, including AM1220 (Item No. 9001055), AM1241 (Item No. 10010118), and AM1248 (Item No. 11282).1 The addition of a tetramethylcyclopropyl group has, in some cases, increased selectivity of synthetic CBs for the peripheral CB2 receptor.2 The physiological and toxicological properties of this compound have not been established. This product is intended for forensic and research applications. | ||
|
11537652
Created by
admin on Sat Dec 16 11:51:14 GMT 2023 , Edited by admin on Sat Dec 16 11:51:14 GMT 2023
|
PRIMARY | |||
|
895155-25-6
Created by
admin on Sat Dec 16 11:51:14 GMT 2023 , Edited by admin on Sat Dec 16 11:51:14 GMT 2023
|
PRIMARY | |||
|
AB-005
Created by
admin on Sat Dec 16 11:51:14 GMT 2023 , Edited by admin on Sat Dec 16 11:51:14 GMT 2023
|
PRIMARY | AB-005 or (1-((1-methyl-2-piperidinyl)methyl)-1H-indol-3-yl)(2,2,3,3-tetramethylcyclopropyl)-methanone is a designer drug offered by online vendors as a cannabimimetic agent. The structure and pharmacological activity of AB-005 was published in 2010, prior to its commercial availability in 2012, where it was reported to have high affinity for both CB1 (Ki = 5.5 nM) and CB2 receptors (Ki = 0.48 nM). AB-005 features groups found in other previously reported synthetic cannabinoids: the tetramethylcyclopropane group of UR-144 and XLR-11 as well as the (1-methyl-2-piperidinyl)methyl substituent of AM-1248 and AM-1220. No information regarding the in vivo activity of AB-005 has been published, and only anecdotal reports are known of its psychoactivity in humans. Psychoactive products in New Zealand containing this drug have been given interim approval under recent psychoactive substances legislation. |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ACTIVE MOIETY |
